Pyxis Oncology

Boston, United States

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Jun 2026

Post-IPO Equity

Biotechnology Health Care Oncology Pharmaceutical

Top Investors

RA Capital ManagementJanus Henderson InvestorsRTW InvestmentsPerceptive AdvisorsBlue Owl

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Pyxis Oncology

Who are Pyxis Oncology's investors?

Pyxis Oncology's investors include RA Capital Management, Janus Henderson Investors, RTW Investments, Perceptive Advisors, Blue Owl.

Where is Pyxis Oncology headquartered?

Pyxis Oncology is headquartered in Boston, United States.

What does Pyxis Oncology do?

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

What stage is Pyxis Oncology at?

Pyxis Oncology is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 30, 2026.

MLA

"Pyxis Oncology — Funding & Investors." VCBacked, June 30, 2026, https://www.vcbacked.co/company/pyxis-oncology. Accessed July 1, 2026.

APA

VCBacked. (2026). Pyxis Oncology — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/pyxis-oncology

Wikipedia (cite web)

{{cite web |title=Pyxis Oncology — Funding & Investors |url=https://www.vcbacked.co/company/pyxis-oncology |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 30, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.